We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.44B
AUM Growth
-$517M
Cap. Flow
-$1.1B
Cap. Flow %
-20.26%
Top 10 Hldgs %
16.51%
Holding
1,406
New
141
Increased
183
Reduced
106
Closed
202

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$60M
2
ALL icon
Allstate
ALL
+$46.9M
3
WFC icon
Wells Fargo
WFC
+$45.7M
4
NI icon
NiSource
NI
+$41.1M
5
BNY
Bank of New York Mellon
BNY
+$41M

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Financials 12.39%
3 Healthcare 3.91%
4 Consumer Discretionary 3.9%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNACW
976
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$165K ﹤0.01%
16,666
HUMAW icon
977
Humacyte Inc Warrant
HUMAW
$1.55M
$163K ﹤0.01%
50,000
CMRAW
978
DELISTED
Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
$161K ﹤0.01%
100,000
CRBU icon
979
Caribou Biosciences
CRBU
$159M
$160K ﹤0.01%
15,207
-79,793
-84% -$744K
RRGB icon
980
Red Robin
RRGB
$134M
$153K ﹤0.01%
22,756
CLAA.WS
981
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$149K ﹤0.01%
15,000
SBIGW
982
DELISTED
SpringBig Holdings, Inc. Warrant
SBIGW
$148K ﹤0.01%
157,934
SLACW
983
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$147K ﹤0.01%
15,000
LAXXR
984
DELISTED
8i Acquisition 2 Corp Rights
LAXXR
$144K ﹤0.01%
300,000
GHL
985
DELISTED
Greenhill & Co., Inc.
GHL
$143K ﹤0.01%
24,051
SMHI icon
986
SEACOR Marine Holdings
SMHI
$217M
$139K ﹤0.01%
24,740
VIEWW
987
DELISTED
View, Inc. Warrant
VIEWW
$134K ﹤0.01%
100,000
VRA icon
988
Vera Bradley
VRA
$108M
$131K ﹤0.01%
43,543
PGYWW
989
Pagaya Technologies Ltd Warrants
PGYWW
$1.26M
$126K ﹤0.01%
69,600
+19,600
+39% +$9.51K
SLAMW
990
DELISTED
Slam Corp. warrant
SLAMW
$124K ﹤0.01%
12,500
SPKBW
991
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
$124K ﹤0.01%
12,500
FRGE
992
DELISTED
Forge Global Holdings
FRGE
$120K ﹤0.01%
4,579
MRNS
993
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$117K ﹤0.01%
17,565
DADA
994
DELISTED
Dada Nexus
DADA
$110K ﹤0.01%
23,316
+1,385
+6% +$9.14K
VOR icon
995
Vor Biopharma
VOR
$1.08B
$107K ﹤0.01%
1,338
CBAY
996
DELISTED
Cymabay Therapeutics
CBAY
$106K ﹤0.01%
30,360
ABUS icon
997
Arbutus Biopharma
ABUS
$875M
$103K ﹤0.01%
53,940
AVDL
998
DELISTED
Avadel Pharmaceuticals
AVDL
$103K ﹤0.01%
20,500
CECO icon
999
Ceco Environmental
CECO
$4.14B
$103K ﹤0.01%
11,681
ABOS icon
1000
Acumen Pharmaceuticals
ABOS
$160M
$101K ﹤0.01%
10,092

Similar funds

LMR Partners's Q3 2022 Portfolio in Review

As of Q3 2022, LMR Partners held 1,406 positions worth $5.44B, down 8.7% from $5.96B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

LMR Partners withdrew a net $1.1B in Q3 2022, closing 202 positions and reducing 106 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $264M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Allstate worth $47M.

  • LMR Partners's largest Q3 2022 buy was Allstate: 377,327 shares worth $47M.
  • LMR Partners added most to American Express in Q3 2022, an estimated $60M increase.
  • LMR Partners's biggest Q3 2022 reduction was TSMC, cutting an estimated $179M.
  • LMR Partners fully exited State Street SPDR S&P 500 ETF Trust in Q3 2022, selling an estimated $264M.
  • LMR Partners's ten largest holdings make up 17% of its $5.44B portfolio in Q3 2022.
  • LMR Partners opened 141 new positions and closed 202 in Q3 2022.
  • LMR Partners's portfolio value fell 8.7% quarter-over-quarter to $5.44B.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.